Consun Pharmaceutical Group Limited (1681.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.02B |
| Enterprise Value | 10.95B |
| P/E Ratio | 8.55 |
| PEG Ratio | 0.55 |
| Price/Sales Ratio | 2.67 |
| Price/Book Ratio | 2.04 |
| Enterprise/Revenue | 2.36 |
| Enterprise/EBITDA | 6.67 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.32 |
| Operating Margin | 0.35 |
AD
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | 0.24 |
Income Statement
| Revenue | 3.42B |
| Revenue/Share | 4.01 |
| Gross Profit | 2.67B |
| EBITDA | 1.21B |
| Net Income | 1.08B |
| Diluted EPS | 1.26 |
Balance Sheet
| Total Cash | 3.95B |
| Total Cash/Share | 4.63 |
| Total Debt | 213.01M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 3.22 |
| Book Value Per Share | 5.69 |
Price History
| 52-Week Change | 12.34 |
| 52-Week High | 19.35 |
| 52-Week Low | 10.8 |
| Moving Average 50 Days | 15 |
| Moving Average 200 Days | 16.01 |
Statistics
| Average Volume | 2M |
| Shares Outstanding | 839.79M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.63 |
| Trailing Annual Dividend Yield | 5.81 |
| Payout Ratio | 0.46 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
